en
Scientific article
English

Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients

Published inClinical transplantation, vol. 25, no. 4, p. 660-669
Publication date2011
Abstract

The aim of this study was to evaluate the tolerability of the conversion from calcineurin inhibitor (CNI) to everolimus (ERL) in maintenance liver transplant (LT) recipients.

Keywords
  • Calcineurin/antagonists & inhibitors
  • Cohort Studies
  • Cyclosporine/therapeutic use
  • Female
  • Follow-Up Studies
  • Graft Rejection/drug therapy
  • Graft Survival
  • Humans
  • Immune Tolerance/drug effects
  • Immunosuppressive Agents/therapeutic use
  • Liver Transplantation
  • Male
  • Middle Aged
  • Sirolimus/analogs & derivatives/therapeutic use
  • Survival Rate
  • Tacrolimus/therapeutic use
  • Treatment Outcome
Citation (ISO format)
VALLIN, Mélanie et al. Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients. In: Clinical transplantation, 2011, vol. 25, n° 4, p. 660–669. doi: 10.1111/j.1399-0012.2010.01370.x
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0902-0063
532views
0downloads

Technical informations

Creation12/17/2012 3:54:00 PM
First validation12/17/2012 3:54:00 PM
Update time03/14/2023 7:55:05 PM
Status update03/14/2023 7:55:05 PM
Last indexation01/16/2024 12:50:26 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack